SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE
0 references·16 citing·46 second hop
ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE (1984)ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A…Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms (2020)Psychedelics in Psychiatry: N…Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention (2020)Psilocybin acutely alters the…Long-term effects of psychedelic drugs: A systematic review (2020)Long-term effects of psychede…Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions (2018)Current perspectives on psych…Psychedelics in the treatment of unipolar mood disorders: a systematic review (2016)Psychedelics in the treatment…Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA (2016)Novel psychopharmacological t…Clinical applications of hallucinogens: A review. (2016)Clinical applications of hall…Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years (2016)Antidepressive, anxiolytic, a…Classic hallucinogens in the treatment of addictions (2015)Classic hallucinogens in the …Psilocybin – Summary of knowledge and new perspectives (2013)Psilocybin – Summary of knowl…Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members (2007)Effects of ayahuasca on psych…Hallucinogen persisting perception disorder: what do we know after 50 years? (2003)Hallucinogen persisting perce…Altered states: the clinical effects of Ecstasy (2003)Altered states: the clinical …A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences (2000)A Review of the Nonmedical Us…Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)Dose-Response Study of N,N-Di…Can Drugs Be Used to Enhance the Psychotherapeutic Process? (1986)Can Drugs Be Used to Enhance …Psychopharmacology: The Third Generation of Progress. (1988)American Journal of Psychiatry 1844-1994 (1994)Ketamine associated psychedelic effects and dependence. (2003)Ketamine (2006)The NEW ENGLAND JOURNAL of MEDICINE (2009)Hallucinogens (2004)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Human hallucinogen research: guidelines for safety (2008)Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD (2017)Developing Guidelines and Competencies for the Training of Psychedelic Therapists (2017)DMT Models the Near-Death Experience (2018)Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)The hallucinogenic world of tryptamines: an updated review (2015)Neuropharmacology of N,N-dimethyltryptamine (2016)Cessation and reduction in alcohol consumption and misuse after psychedelic use (2019)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development (2018)The Therapeutic Potential of Psilocybin (2021)LYSERGIC ACID DIETHYLAMIDE (1960)Psychological and Cognitive Effects of Long-Term Peyote Use Among Native Americans (2005)Harm potential of magic mushroom use: A review (2011)Diagnostic and Statistical Manual of Mental Disorders (2013)Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil (1996)Pharmacokinetics of Hoasca alkaloids in healthy humans (1999)Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics (2003)Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness (2018)N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function (2018)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Self unbound: ego dissolution in psychedelic experience (2017)Classical psychedelics for the treatment of depression and anxiety: A systematic review (2019)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects (2021)Default Mode Network Modulation by Psychedelics: A Systematic Review (2022)Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials (2022)The size and burden of mental disorders and other disorders of the brain in Europe 2010 (2011)Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 (2013)Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015)Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity (2022)A non-hallucinogenic LSD analog with therapeutic potential for mood disorders (2023)Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review (2023)Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression (2017)The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion (2019)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2016Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years306 cited
  • 1994Dose-Response Study of N,N-Dimethyltryptamine in Humans291 cited
  • 2013Psilocybin – Summary of knowledge and new perspectives275 cited
  • 2020Long-term effects of psychedelic drugs: A systematic review258 cited
  • 2016Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA239 cited
  • 2020Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms231 cited
  • 2000A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences229 cited
  • 2015Classic hallucinogens in the treatment of addictions226 cited
  • 2003Hallucinogen persisting perception disorder: what do we know after 50 years?219 cited
  • 2007Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members205 cited
  • 2016Clinical applications of hallucinogens: A review.201 cited
  • 2018Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions190 cited
  • 2003Altered states: the clinical effects of Ecstasy190 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2020
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention
188 cited
  • 1986Can Drugs Be Used to Enhance the Psychotherapeutic Process?187 cited
  • 2016Psychedelics in the treatment of unipolar mood disorders: a systematic review185 cited